Omalizumab in severe allergic asthma

This guideline advises that Omalizumab can be used in the treatment of asthma. It is a monoclonal antibody that binds to IgE and is given every 2 to 4 weeks subcut. We may start seeing patients treated with this, so worth knowing about it. Treatment is to be started and maintained by specialists only. Quite a lot of criteria must be met before use, so it'll only be used in the most severe asthma, where allergy testing has been positive.

Louise Hudman

I'm a freelance GP locum in Winchester & Southampton locum chambers, and Pallant Medical Chambers Clinical Guidelines Lead Partner.

Use the NASGP CPD templates to record your reflections.

Latest posts by Louise Hudman (see all)

No Comments Yet.

Leave your comments